BridgeMD
New treatment option for PreTerm Neonate
Official title PEEP FOR LUNG RECRUITMENT IN PRETERM INFANTS-EIT STUDY
ClinicalTrials.gov ID: NCT06705257
What this study is testing
- What it's testing
- Babies born early (under 32 weeks) are at risk of developing lung problems after birth. A major reason for this is that the lungs are not fully developed.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 to 32
You may be able to join if
- Gestational age \<32 weeks based on mother's last menstrual period or first trimester ultrasound dating.
- Receiving either CPAP or mechanical ventilation respiratory support.
- Informed written consent from one of the parents.
- Within the first two weeks of life. Investigators pragmatically chose this period, as there could be considerable lung injury after the first two...
You likely can't join if
- Major congenital malformations including congenital lung disease and congenital heart disease as ascertained by the medical team.
- Infants diagnosed with pneumothorax i.
- Receiving high frequency mechanical ventilation.
- Infants with concerns of skin integrity.
The study team makes the final eligibility decision.
Where it's taking place
- Middlesbrough, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 weeks to 32 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Middlesbrough, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.